Denali Advisors LLC Bluebird Bio, Inc. Transaction History

Denali Advisors LLC

  • $916 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 09, 2023
SELL
$5.77 - $8.49 $65,778 - $96,786
-11,400 Reduced 54.29%
9,600 $66,000
Q3 2022

Oct 25, 2022
SELL
$3.75 - $7.39 $16,875 - $33,255
-4,500 Reduced 17.65%
21,000 $133,000
Q2 2022

Jul 18, 2022
BUY
$2.94 - $5.23 $45,276 - $80,542
15,400 Added 152.48%
25,500 $106,000
Q4 2021

Jan 21, 2022
BUY
$8.96 - $16.31 $90,496 - $164,731
10,100 New
10,100 $101,000

Others Institutions Holding BLUE

# of Institutions
151
Shares Held
63.4M
Call Options Held
264K
Put Options Held
428K
View Full List

About bluebird bio, Inc.

BLUE Quotes by TradingView
  • Ticker BLUE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 77,121,800
  • Market Cap $27M
  • Description
  • bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...
More about BLUE
Track This Portfolio

Track Denali Advisors LLC Portfolio

Follow Denali Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Denali Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Denali Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email